Overview
DFTX market data
Price History
DFTX price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$2.06 Diluted earnings per share over the trailing twelve months.
- Beta
- 2.30 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $7.96 – $49.20 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $5.7K · P/B 4.04.
Company news
Piper Sandler Reiterates Overweight on Definium Therapeutics, Raises Price Target to $73Benzinga · Jul 24, 2026, 3:01 PM
Why Is GH Research Stock Trading Higher on Thursday?Benzinga · Jul 16, 2026, 4:36 PM
Definium Therapeutics Announces Launch Of Wired For Worry, New Healthcare Provider Disease Education Initiative Focused On Generalized Anxiety DisorderBenzinga · Jul 16, 2026, 11:06 AM
Definium Therapeutics shares are trading higher. The company announced results from a healthcare claims study on treatment patterns in Generalized Anxiety Disorder patients.Benzinga · Jul 14, 2026, 5:29 PM
Definium Therapeutics Study Shows High Discontinuation In GAD, Spotlighting Need For Improved Efficacy And TolerabilityBenzinga · Jul 14, 2026, 11:07 AM
Stifel Maintains Buy on Definium Therapeutics, Raises Price Target to $60Benzinga · Jul 8, 2026, 1:35 PM
Canaccord Genuity Maintains Buy on Definium Therapeutics, Lowers Price Target to $58Benzinga · Jun 30, 2026, 3:30 PM
Top 3 Health Care Stocks That May Keep You Up At Night In JuneBenzinga · Jun 30, 2026, 1:00 PM
Acuity Posts Strong Q3 Results, Joins BlackBerry, MillerKnoll, Qualcomm And Other Big Stocks Moving Higher On ThursdayBenzinga · Jun 25, 2026, 2:01 PM
8-K filing — Definium Therapeutics, Inc. (DFTX)SEC EDGAR · Jun 24, 2026, 9:14 PM